Life Sciences Times

Mirador Therapeutics Licenses Long-Acting Anti-C5a Antibody from Kira Pharmaceuticals

Bayer and Henry Ford Health Partner to Expand Patient Access to Clinical Trials

Inflammasome Therapeutics Reports Positive Phase 2 Results for K8 in Geographic Atrophy

Aqemia and Sanofi Expand AI-Driven Drug Discovery Collaboration

Takeda’s Zasocitinib Shows High Skin-Clearance Rates Across Hard-to-Treat Psoriasis Sites

DePuy Synthes Acquires Expanding Innovations to Expand Spine Portfolio

LightForce Orthodontics Appoints Erica Rogers Chief Executive Officer

Syntis Bio Reports Positive Initial Phase 1/1b Data for Obesity Drug SYNT-101

Foundation Medicine Launches Initiative on Cancer Biomarker Test Quality

Niagen Bioscience Appoints Abhijit Kale, Ph.D., Senior Director of Global External Research